The impact of histological subtypes on outcome in patients with mantle cell lymphoma treated with or without autologous stem cell transplant

被引:0
|
作者
Zulfiqar, Muhammad I. [1 ]
Weisenburger, Dennis D. [1 ]
Loberiza, Fausto R. [1 ]
Vose, Juli M. [1 ]
Bierman, Philip J. [1 ]
Bociek, R. Gregory [1 ]
Armitage, James O. [1 ]
机构
[1] Univ Nebraska Med Ctr, Omaha, NE USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1904
引用
收藏
页码:565A / 565A
页数:1
相关论文
共 50 条
  • [21] PREDICTORS Of OUTCOME OF MANTLE CELL LYMPHOMA IN PATIENTS WITH PROGRESSIVE DISEASE FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT)
    Al-Farsi, K.
    Nagy, T.
    Keating, A.
    Crump, M.
    Kuruvilla, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 38 - 39
  • [22] Stem cell transplant for mantle cell lymphoma in Taiwan
    Yu-Hung Wang
    Ching-Yun Hsieh
    Liang-Tsai Hsiao
    Tung-Liang Lin
    Yi-Chang Liu
    Ming Yao
    Tran-Der Tan
    Bor-Sheng Ko
    Scientific Reports, 12
  • [23] Stem cell transplant for mantle cell lymphoma in Taiwan
    Wang, Yu-Hung
    Hsieh, Ching-Yun
    Hsiao, Liang-Tsai
    Lin, Tung-Liang
    Liu, Yi-Chang
    Yao, Ming
    Tan, Tran-Der
    Ko, Bor-Sheng
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Quality of Life during Survivorship Following Autologous Stem Cell Transplant for Mantle Cell Lymphoma
    Di, Mengyang
    Ho, Carrie, I
    Smith, Stephen D.
    Shadman, Mazyar
    Ujjani, Chaitra S.
    Lynch, Ryan C.
    Poh, Christina
    Raghunathan, Vikram
    Till, Brian G.
    Warren, Edus H.
    Gopal, Ajay K.
    Lee, Stephanie J.
    BLOOD, 2024, 144 : 5116 - 5117
  • [25] High dose chemotherapy with autologous stem cell transplant (ASCT) for mantle cell lymphoma (MCL).
    Segota, E
    Pohlman, B
    Jin, T
    Kuczkowski, E
    Rybicki, L
    Kalaycio, M
    Sobecks, R
    Andresen, S
    Bolwell, U
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 602S - 602S
  • [26] Impact of mantle cell lymphoma contamination of autologous stem cell grafts on outcome after high-dose chemotherapy
    Roerden, M.
    Wirths, S.
    Soekler, M.
    Bethge, W. A.
    Lengerke, C.
    Vogel, W.
    Walz, J. S.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 152 - 153
  • [27] Impact of Mantle Cell Lymphoma Contamination of Autologous Stem Cell Grafts on Outcome after High-Dose Chemotherapy
    Roerden, Malte
    Wirths, Stefan
    Soekler, Martin
    Bethge, Wolfgang A.
    Vogel, Wichard
    Walz, Juliane S.
    CANCERS, 2021, 13 (11)
  • [28] Autologous stem cell transplantation and rituximab for mantle cell lymphoma
    Capote, F.
    Gonzalez-Barca, E.
    Bergua, J.
    Calvo, J. Fernandez
    Oriol, A.
    Garcia-Boyero, R.
    Ramirez, M.
    Caballero, D.
    Romero, A.
    Perez, E.
    Queizan, J.
    Pascual, M.
    Cantalapiedra, A.
    Giraldo, P.
    Palomera, L.
    Guinot, M.
    Ribera, J.
    Leon, A.
    Gil, J.
    Fernandez-Sevilla, A.
    ANNALS OF ONCOLOGY, 2008, 19 : 174 - 174
  • [29] AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) FOR MANTLE CELL LYMPHOMA
    Mabindra, A.
    Copelan, E.
    Bolwell, B.
    Rybicki, L.
    Dean, R.
    Kalaycio, M.
    Sobecks, R.
    Ferraro, C.
    Cherni, K.
    Pohlman, B.
    Sweetenham, J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 64 - 65
  • [30] Autologous hematopoietic stem cell transplantation for mantle cell lymphoma
    Vose, JM
    Bierman, PJ
    Weisenburger, DD
    Lynch, JC
    Bociek, G
    Chan, WC
    Greiner, TC
    Armitage, JO
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) : 640 - 645